Intervention: Epirubicin with Cyclophosphamide, followed by a Taxane
Found 97 matching trials
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
PHASE3
This two-arm, randomized, open-label, multicenter study will evaluate the e...
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel
PHASE3
This is an Asia-Pacific regional, randomized, double-blind, multicenter tri...
Status
Completed
Location
The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA)
A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer
PHASE3
This review will evaluate the efficacy and safety of SHR1210 (Camrelizumab)...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer
PHASE3
This study compares two chemotherapy regimens as adjuvant treatment for bre...
Status
Completed
Location
Department of Oncology, Helsinki University Central Hospital, Finland